Incidence, demographics, and survival of malignant hemangioendothelioma in the United States

ConclusionsMalignant hemangioendothelioma is ultra-rare but meaningfully impacts affected patients. These data may provide benchmarks for comparison of new approaches to hemangioendothelioma therapy and highlight poor survival outcomes.

Source: Cancer Medicine - June 1, 2023 Category: Cancer & Oncology Authors: Kelly G. Paulson, Vinod Ravi, Brian P. Rubin, Min Park, Elizabeth T. Loggers, Lee D. Cranmer, Michael J. Wagner Tags: RESEARCH ARTICLE Source Type: research